Company profile INBX
After 39 days of this quarter the interest is at 145.0. Based on that we can calculate that during remaining 52 days it will total up to 338.0. Inhibrx expected interest is significantly higher compared to previous quarter (+436.5%) and same quarter last year (+344.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 18 | 49 172.2% QoQ | 82 67.3% QoQ | 17 -79.3% QoQ |
| 2020 | 25 38.9% YoY 47.1% QoQ | 47 -4.1% YoY 88.0% QoQ | 170 107.3% YoY 261.7% QoQ | 108 535.3% YoY -36.5% QoQ |
| 2021 | 54 116.0% YoY -50.0% QoQ | 90 91.5% YoY 66.7% QoQ | 80 -52.9% YoY -11.1% QoQ | 125 15.7% YoY 56.2% QoQ |
| 2022 | 57 5.6% YoY -54.4% QoQ | 89 -1.1% YoY 56.1% QoQ | 110 37.5% YoY 23.6% QoQ | 55 -56.0% YoY -50.0% QoQ |
| 2023 | 76 33.3% YoY 38.2% QoQ | 70 -21.3% YoY -7.9% QoQ | 55 -50.0% YoY -21.4% QoQ | 63 14.5% YoY 14.5% QoQ |
| 2024 | 145 90.8% YoY 130.2% QoQ | - | - | - |
The average 5 years interest of Inhibrx was 6.07 per week. The last year interest of Inhibrx compared to the last 5 years has changed by 15.65%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 105.26%.
There is not enough data for Inhibrx Inhibrx biopharmaceutical to provide analysis
There is not enough data for Inhibrx Inhibrx biopharmaceutical to provide correlation calculation
There is not enough data for Inhibrx Inhibrx biopharmaceutical to provide analysis
There is not enough data for Inhibrx pipeline to provide analysis
There is not enough data for Inhibrx pipeline to provide correlation calculation
There is not enough data for Inhibrx pipeline to provide analysis
There is not enough data for INBRX-109 to provide analysis
There is not enough data for INBRX-109 to provide correlation calculation
There is not enough data for INBRX-109 to provide analysis
There is not enough data for INBRX-105 to provide analysis
There is not enough data for INBRX-105 to provide correlation calculation
There is not enough data for INBRX-105 to provide analysis
There is not enough data for INBRX-101 to provide analysis
There is not enough data for INBRX-101 to provide correlation calculation
There is not enough data for INBRX-101 to provide analysis
There is not enough data for INBRX-106 to provide analysis
There is not enough data for INBRX-106 to provide correlation calculation
There is not enough data for INBRX-106 to provide analysis
Google Trends for tetravalent agonist of death receptor 5
Not enough data for reliable calculations!
There is not enough data for tetravalent agonist of death receptor 5 to provide analysis
There is not enough data for tetravalent agonist of death receptor 5 to provide correlation calculation
There is not enough data for tetravalent agonist of death receptor 5 to provide analysis
There is not enough data for conditional agonist of programmed death-ligand 1 to provide analysis
There is not enough data for conditional agonist of programmed death-ligand 1 to provide correlation calculation
There is not enough data for conditional agonist of programmed death-ligand 1 to provide analysis
There is not enough data for alpha-1 antitrypsin (AAT)-Fc fusion protein to provide analysis
There is not enough data for alpha-1 antitrypsin (AAT)-Fc fusion protein to provide correlation calculation
There is not enough data for alpha-1 antitrypsin (AAT)-Fc fusion protein to provide analysis
There is not enough data for hexavalent agonist of OX40. to provide analysis
There is not enough data for hexavalent agonist of OX40. to provide correlation calculation
There is not enough data for hexavalent agonist of OX40. to provide analysis